What clinical trials are currently recruiting in Iowa?

TrialFinder lists 756 recruiting clinical trials with sites in or near Iowa. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in Iowa?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in Iowa?

Trials in Iowa cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in Iowa?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

756 Recruiting Trials

Clinical Trials in Iowa

Browse 756 recruiting clinical trials currently enrolling participants in Iowa. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 756 recruiting trials in Iowa

NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study

N/A Jacksonville, Florida +4 sites · Intracranial Aneurysm

Recruiting

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

PHASE2 Phoenix, Arizona +4 sites · CLOVES Syndrome, Klippel Trenaunay Syndrome

Recruiting

EVERO Drug-coated Balloon (DCB) Randomized Trial

NA New Haven, Connecticut +4 sites · Peripheral Arterial Disease, Peripheral Vascular Disease

Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

PHASE2 Phoenix, Arizona +4 sites · Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Recruiting

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

PHASE3 Birmingham, Alabama +4 sites · Acute Migraine

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

PHASE2 Birmingham, Alabama +4 sites · Sarcomatoid Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8

Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

PHASE2 Anchorage, Alaska +4 sites · Resectable Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma

Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

PHASE3 Birmingham, Alabama +4 sites · Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma

Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

PHASE2 Decatur, Alabama +4 sites · Atherosclerotic Cardiovascular Disease, End Stage Kidney Disease

Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia

Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

PHASE2 Phoenix, Arizona +4 sites · Muscle Invasive Bladder Urothelial Carcinoma, Stage IV Bladder Urothelial Carcinoma AJCC v7

Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

PHASE3 Birmingham, Alabama +4 sites · Primary Biliary Cholangitis

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

PHASE3 Birmingham, Alabama +4 sites · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8

Recruiting

See all 756 results in Iowa

Check Your Eligibility

Create a free profile and our AI will match you to trials in Iowa you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in Iowa

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon